lopinavir has been researched along with Bone Diseases, Metabolic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belloso, W; Boyd, MA; Cooper, DA; Emery, S; Ferret, S; Hoy, J; Mallon, PW; Martin, A; Moore, C; Phanuphak, P | 1 |
1 trial(s) available for lopinavir and Bone Diseases, Metabolic
Article | Year |
---|---|
Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy.
Topics: Absorptiometry, Photon; Adult; Argentina; Bone Density; Bone Diseases, Metabolic; Female; Femur; HIV Infections; HIV Protease Inhibitors; Humans; India; Lopinavir; Lumbar Vertebrae; Malaysia; Male; Osteoporosis; Prevalence; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Risk Factors; Ritonavir; South Africa; Thailand; Treatment Outcome | 2013 |